u 74006f has been researched along with Allergic Encephalomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feasby, TE; Hahn, AF; Lovgren, D; Wilkie, L | 1 |
| Dijkstra, CD; Polman, CH; Sontrop, K; Uitdehaag, BM | 1 |
| Hall, ED; Karlik, SJ; Stavraky, RT | 1 |
3 other study(ies) available for u 74006f and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F).
Topics: Animals; Axons; Brain; Encephalomyelitis, Autoimmune, Experimental; Free Radical Scavengers; Lipid Peroxidation; Male; Myosins; Nerve Degeneration; Pregnatrienes; Rats; Sciatic Nerve | 1994 |
The effect of the 21-aminosteroid U74006F on the clinical course of acute experimental allergic encephalomyelitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Methylprednisolone; Pregnatrienes; Rats; Rats, Inbred Lew | 1996 |
Comparison of tirilazad mesylate (U-74006F) and methylprednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Pregnatrienes; Reference Values; Treatment Outcome | 1996 |